Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Lipocine Inc.
Plus deals involving Sun's SPARC/Visiox, Twist/Sosei, BeiGene, Leads Biolabs, Qilu/Arbutus, Hansoh/Keros, Simcere/Avilex and Cytokinetics/Ji Xing.
Janssen Biotech adds to its bispecific antibody pipeline for cancer via pair of collaborations. Ipsen and Accent pair up to investigate new target for acute myeloid leukemia.
Public Company Edition: Three companies postponed or withdrew their offerings, but drug developers continue to pursue IPOs. Also, Biocon, BMS and Epizyme raised money through new debt, Five Prime capitalized on positive data and Synthetic Biologic engaged a strategic advisor.
The latest drug development news and highlights from the Pink Sheet FDA Performance Tracker.
- Specialty Pharmaceuticals
- Controlled Release
- Large Molecule
Drug Discovery Tools